IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo

被引:146
|
作者
Sasaki, H
Hou, L
Belani, A
Wang, CY
Uchiyama, T
Müller, R
Stashenko, P
机构
[1] Forsyth Inst, Dept Cytokine Biol, Boston, MA 02115 USA
[2] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
[3] Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Boston, MA 02215 USA
来源
JOURNAL OF IMMUNOLOGY | 2000年 / 165卷 / 07期
关键词
D O I
10.4049/jimmunol.165.7.3626
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Periapical bone resorption occurs following infection of the dental pulp and is mediated mainly by IL-1 alpha in the murine model. The production and activity of IL-1 alpha is modulated by a network of regulatory cytokines, including those produced hy Th1 (proinflammatory) and Th2 (anti-inflammatory) subset T cells, This study was designed to assess the functional role of the Th2-type cytokines IL-4 and IL-10 in infection-stimulated bone resorption in vivo. The dental pulps of the first molars were exposed and infected with a mixture of four common endodontic pathogens, and bone destruction was determined by micro-computed tomography at sacrifice on day 21, The results demonstrate that IL-10(-/-) mice had significantly greater infection-stimulated bone resorption in vivo compared with wild-type mice (p < 0.001), whereas IL-4(-/-) exhibited no increased resorption, IL-10(-/-) had markedly elevated IL-1 alpha production within periapical inflammatory tissues (>10-fold) compared with wild type (p < 0.01), whereas IL-4(-/-) exhibited decreased IL-1 alpha production (p < 0.05). IL-10 also suppressed IL-1 alpha production by macrophages in a dose-dependent fashion in vitro, whereas IL-4 had weak and variable effects, We conclude that IL-10, but not IL-4, is an important endogenous suppressor of infection-stimulated bone resorption in vivo, likely acting via inhibition of IL-1 alpha expression.
引用
收藏
页码:3626 / 3630
页数:5
相关论文
共 50 条
  • [1] The role of IL-4 and IL-10 cytokines in controlling an anti-tumor response in vivo
    Terres, G
    Coffman, RL
    INTERNATIONAL IMMUNOLOGY, 1998, 10 (06) : 823 - 832
  • [2] Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites
    MacDonald, AS
    Maizels, RM
    Lawrence, RA
    Dransfield, I
    Allen, JE
    JOURNAL OF IMMUNOLOGY, 1998, 160 (03): : 1304 - 1312
  • [3] Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils
    Nakajima, H
    Gleich, GJ
    Kita, H
    JOURNAL OF IMMUNOLOGY, 1996, 156 (12): : 4859 - 4866
  • [4] IL-4, IL-10 and IL-13 in acute myelogenous leukemia
    Bruserud, O
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (03) : 187 - 198
  • [5] Correlation analysis of IL-4, IL-10 and APN levels with postoperative infection of colorectal cancer
    He, Jianyun
    Wang, Zhiyan
    Zhang, Sihai
    ONCOLOGY LETTERS, 2019, 17 (02) : 1603 - 1608
  • [6] Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10
    Hill, KE
    Pigmans, M
    Fujinami, RS
    Rose, JW
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 85 (01) : 44 - 51
  • [7] IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes
    Kambayashi, T
    Jacob, CO
    Strassmann, G
    CELLULAR IMMUNOLOGY, 1996, 171 (01) : 153 - 158
  • [8] IL-4 induces IL-10 in Th1 cells
    Mitchell, R.
    Hassan, M.
    Wraith, D.
    IMMUNOLOGY, 2013, 140 : 156 - 156
  • [9] BOTH IL-4 AND IL-10 ARE NEEDED FOR INDUCTION OF ORAL TOLERANCE
    RIZZO, LV
    STIFF, LR
    MILLERRIVERO, NE
    CHAN, CC
    WIGGERT, B
    NUSSENBLATT, RB
    CASPI, RR
    FASEB JOURNAL, 1995, 9 (03): : A203 - A203
  • [10] In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia
    Tao, M
    Li, BR
    Nayini, J
    Sivaraman, S
    Song, SW
    Larson, A
    Toofanfard, M
    Chen, H
    Venugopal, P
    Preisler, HD
    LEUKEMIA & LYMPHOMA, 2001, 41 (1-2) : 161 - 168